Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity

Wednesday, September 04, 2019

Velabs Therapeutics GmbH a biotech company focused on the rapid screening of functional therapeutic antibodies today announces that it has entered into a partnership agreement with alytas therapeutics GmbH alytas to jointly develop modulatory and fun...

Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki

Tuesday, September 03, 2019

Valo Therapeutics Limited an immunooncology company developing tumour antigencoated oncolytic viruses as therapeutic vaccines today announced that it has licensed proprietary PeptiENVTM technology from Helsinki University that enables the coating of...

Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America

Tuesday, September 03, 2019

Helsinn a Swiss pharmaceutical group focused on building quality cancer care products together with Blanver Farmoqumica e Farmacutica SA a Brazilian company focused on innovative products with high quality medicines and active pharmaceutical ingredie...

DarwinHealth announces a scientific collaboration with Celgene on a discovery platform in systems biology

Saturday, August 31, 2019

DarwinHealth today announced a multiyear scientific collaboration with Celgene Corporation Celgene to use algorithms based on quantitative systems biology technologies that also underpin the evidence of diagnosis approved by the Reforms on the Improv...

La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA™ (angiotensin II)

Friday, August 30, 2019

La Jolla Pharmaceutical Company a leader in the discovery development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from lifethreatening diseases today announced that the European Commi...

Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment

Thursday, August 29, 2019

Adaptimmune Therapeutics plc a leader in Tcell therapy to treat cancer and NoileImmune Biotech Inc Tokyo Japan a biotechnology company focusing on the development of innovative cancer immunotherapies today announced that they will codevelop nextgener...

European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer

Thursday, August 29, 2019

Roche today announced that the European Commission has approved Tecentriq atezolizumab plus chemotherapy Abraxane paclitaxel proteinbound particles for injectable suspension albuminbound nabpaclitaxel for the treatment of adult patients with unresect...

Machavert Pharmaceuticals Signs Exclusive License Agreement to Control RAL GTPase Inhibitors against KRAS Cancers

Wednesday, August 28, 2019

Machavert Pharmaceuticals a preclinical stage pharmaceutical company focused on precision medicine cancer therapies announced today that it has obtained a full exclusive license on RAL GTPase RAL inhibitors from the University of Colorado The license...

Harbour BioMed and PPD Form Strategic Collaboration to Develop Innovative Therapeutics for Oncology and Immunology

Wednesday, August 28, 2019

Harbour BioMed HBM a global clinicalstage biopharmaceutical company and Pharmaceutical Product Development LLC PPD a leading global contract research organization CRO today announced a strategic collaboration to develop HBMs innovative therapeutics i...

ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

Tuesday, August 27, 2019

ADC Therapeutics an oncology drug discovery and development company that specializes in the development of antibody drug conjugates ADCs and Freenome a biotechnology company that has pioneered the most comprehensive multiomics platform for early canc...